Cargando…

ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies

For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/
https://www.ncbi.nlm.nih.gov/pubmed/33368829
http://dx.doi.org/10.1002/onco.13657
_version_ 1783648565665464320
collection PubMed
description For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology.
format Online
Article
Text
id pubmed-7869116
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-78691162021-02-17 ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies Oncologist Conference Perspectives For patients with blood cancers, the COVID‐19 mortality rate is approximately 20% overall and 33% for those who require hospitalization, according to new data from the ASH Research Collaborative COVID‐19 Registry for Hematology. John Wiley & Sons, Inc. 2020-12-28 2021-02 /pmc/articles/PMC7869116/ /pubmed/33368829 http://dx.doi.org/10.1002/onco.13657 Text en © 2020 AlphaMed Press
spellingShingle Conference Perspectives
ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title_full ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title_fullStr ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title_full_unstemmed ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title_short ASH Registry Offers Insights on COVID‐19 in Patients with Hematologic Malignancies
title_sort ash registry offers insights on covid‐19 in patients with hematologic malignancies
topic Conference Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869116/
https://www.ncbi.nlm.nih.gov/pubmed/33368829
http://dx.doi.org/10.1002/onco.13657